Behind the Mystery: Understanding Blastic Plasmacytoid Dendritic Cell Neoplasm

Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.

Historically, the median survival from the time of diagnosis is anywhere from 8 to 14 months, and without treatment, BPDCN is oftentimes fatal.

The Balancing Act visited the Moffitt Cancer Center in Tampa, Florida to learn about BPDCN from oncologist Dr. Kendra Sweet. She shares the prevalence, who it can affect, and how it can present, as well as treatment options for patients.

Patient Dan Dan Beres was enjoying life with his wife when his diagnosis came out of nowhere. We will hear his story, as well as advice and guidance for patients diagnosed.